Novavax

Can Novavax Convince the FDA Its Vaccine Deserves a Chance?
Can Novavax Convince the FDA Its Vaccine Deserves a Chance?
Motley Fool
Novavax
RSV
vaccines
FDA
clinical trials
Flag link:
Another PhIII RSV failure thumps beleaguered Novavax, but execs claim there's a way forward
Another PhIII RSV failure thumps beleaguered Novavax, but execs claim there's a way forward
Endpoints
RSV
vaccines
Novavax
clinical trials
Flag link:
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
JPMHC 2019
SAGE Therapeutics
SAGE-217
Mersana
Novavax
Denali Therapeutics
AstraZeneca
Amarin
FDA
government shutdown
Flag link:
The Most Promising Biotech Names Heading Into 2019
The Most Promising Biotech Names Heading Into 2019
Investopedia
biotech
AbbVie
Novavax
Amarin
TG Therapeutics
Flag link:
2 Biotech Stocks Poised for Big Gains in 2019
2 Biotech Stocks Poised for Big Gains in 2019
Motley Fool
Amarin
Vascepa
Novavax
ResVax
Flag link:
Why Novavax Is Up 60% in 2018
Why Novavax Is Up 60% in 2018
Motley Fool
Novavax
NanoFlu
ResVax
vaccines
Flag link:
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
Fierce Pharma
GSK
Merck
Sanofi
Pfizer
Novavax
vaccines
Flag link:
Ph III Study of Infant via Maternal Immunization Vaccine for RSV Reaches Milestone
Ph III Study of Infant via Maternal Immunization Vaccine for RSV Reaches Milestone
CP Wire
Novavax
RSV
vaccines
RSV F vaccine
infant via maternal immunization
Flag link:
Novavax’s flu vaccine for older adults shows early promise against Sanofi’s Fluzone
Novavax’s flu vaccine for older adults shows early promise against Sanofi’s Fluzone
Fierce Pharma
Novavax
flu vaccines
Sanofi
NanoFlu
Fluzone
Flag link:
Watch These February Biotech Catalysts
Watch These February Biotech Catalysts
Seeking Alpha
biotech
Dynavax
HEPLISAV-B
vaccines
Novavax
NanoFlu
Nerlynx
Puma Biotechnology
breast cancer
Flag link:
JPM18: Novavax investors cheer RSV vaccine update, then pull back
JPM18: Novavax investors cheer RSV vaccine update, then pull back
Biopharma Dive
Novavax
vaccines
RSV
JPMHC 2018
Flag link:
Novavax makes a case for a do-over on its failed RSV vaccine — but it’s an uphill climb
Novavax makes a case for a do-over on its failed RSV vaccine — but it’s an uphill climb
Endpoints
Novavax
vaccines
RSV
RSV F vaccine
Flag link:
Novavax reports 4Q loss
Novavax reports 4Q loss
Yahoo/AP
Novavax
earnings
Flag link:
JPM: Day 4 round-up
JPM: Day 4 round-up
BioPharma Dive
JPMHC 2017
Novavax
Tesaro
MannKind
Flag link:
7 of the Most Shocking Biotech Pipeline Blowups of 2016
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Motley Fool
biotech
Alnylam
revusiran
Clovis Oncology
rociletinib
Celldex Therapeutics
Rintega
Eli Lilly
solanezumab
Novavax
RSV-F
Arrowhead
ARC-520
ARC-521
ARC-AAT
Biomarin
drisapersen
Flag link:
Novavax aims to rebound with restructuring, more trials
Novavax aims to rebound with restructuring, more trials
BioPharma Dive
Novavax
restructuring
clinical trials
RSV
Flag link:
How the Zika virus could be a major bright spot for Novavax
How the Zika virus could be a major bright spot for Novavax
Bizjournals.com
Zika virus
Novavax
vaccines
RSV
Flag link:
Novavax cuts jobs to push ahead with respiratory vaccine for elderly
Novavax cuts jobs to push ahead with respiratory vaccine for elderly
Yahoo/Reuters
Novavax
layoffs
vaccines
RSV
Flag link:
Novavax's Big Disappointment -- What's Next?
Novavax's Big Disappointment -- What's Next?
Motley Fool
Novavax
vaccines
RSV
RSV-F
Flag link:
Novavax shares plummet more than 80% after vaccine trial fails
Novavax shares plummet more than 80% after vaccine trial fails
Marketwatch
Novavax
vaccines
clinical trials
RSV
Flag link:

Pages